Ana Limon

Ana Limon

Company: Oryzon Genomics

Job title: Senior Vice President- Clinical Development & Medical Affairs


Epigenetic Approaches to Modulate the RAS Pathway 2:30 pm

The development of kinase inhibitor resistance through epigenetic adaptation is mediated by the persistence of a small population of cells that overcome initial drug exposure By selectively targeting the epigenetic mechanisms of cell survival during the early stages of drug response, durable responses to kinase inhibitors may be obtained by preventing the outgrowth of drug-resistant…Read more

day: Day Two Track E

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.